Figure 1.
Schematic representation of the most relevant effects as part of cardiac repair mechanisms and cardiac regenerative effects delivered by administration into the injured heart of exogenous mesenchymal stromal cells (MSC)-extracellular vesicles (EVs) and cardiac progenitor cells (CPC)-EVs. ATMP: Advanced Therapy Medicinal Product.
